Marton Nemeth

Marton Nemeth

Auto-generated profile, based on publicly available information

Marton Nemeth

University of Szeged

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2016 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
DTDomonkos Trásy
Domonkos Trásy
KTKrisztián Tánczos
Krisztián Tánczos
MNMárton Németh
Márton Németh
PHPéter Hankovszky
Péter Hankovszky
ALAndrás Lovas
András Lovas
ZMZsolt Molnar
Zsolt Molnar
Purpose. To investigate whether absolute value of procalcitonin (PCT) or the change (delta-PCT) is better indicator of infection in intensive care patients.Materials and Methods.Post hocanalysis of a prospective observational study. Patients with suspected new-onset infection were included in whom PCT, C-reactive protein (CRP), temperature, and leukocyte (WBC) values were measured on inclusion (t0) and data were also available from the previous day (t-1). Based on clinical and microbiological data, patients were groupedpost hocinto infection- (I-) and noninfection- (NI-) groups.Results. Of the 114 patients, 85 (75%) had proven infection. PCT levels were similar att-1: I-group (median [interquartile range]): 1.04 [0.40–3.57] versus NI-group: 0.53 [0.16–1.68],p=0.444. Byt0PCT levels were significantly higher in the I-group: 4.62 [1.91–12.62] versus 1.12 [0.30–1.66],p=0.018. The area under the curve to predict infection for absolute values of PCT was 0.64 [95% CI = 0.52–0.76],p=0.022; for percentage change: 0.77 [0.66–0.87],p<0.001; and for delta-PCT: 0.85 [0.78–0.92],p<0.001. The optimal cut-off value for delta-PCT to indicate infection was 0.76 ng/mL (sensitivity 80 [70–88]%, specificity 86 [68-96]%). Neither absolute values nor changes in CRP, temperature, or WBC could predict infection.Conclusions. Our results suggest that delta-PCT values are superior to absolute values in indicating infection in intensive care patients. This trial is registered with ClinicalTrials.gov identifier:NCT02311816.

22 February 2019
Verified
Book Chapter
Closed access
PDF file
ZMZsolt Molnar
Zsolt Molnar
MNMarton Nemeth
Marton Nemeth

1 January 2014
Verified
Book Chapter
Closed access
PDF file
KTKrisztián Tánczos
Krisztián Tánczos
MNM. Németh
M. Németh
ZMZsolt Molnar
Zsolt Molnar